The Cigna Group (CI)
| Market Cap | 73.95B |
| Revenue (ttm) | 262.02B |
| Net Income (ttm) | 5.02B |
| Shares Out | 266.93M |
| EPS (ttm) | 18.24 |
| PE Ratio | 15.19 |
| Forward PE | 8.71 |
| Dividend | $6.04 (2.18%) |
| Ex-Dividend Date | Sep 4, 2025 |
| Volume | 1,598,689 |
| Open | 275.43 |
| Previous Close | 274.90 |
| Day's Range | 274.71 - 279.52 |
| 52-Week Range | 256.89 - 370.83 |
| Beta | 0.48 |
| Analysts | Strong Buy |
| Price Target | 382.71 (+38.14%) |
| Earnings Date | Jul 31, 2025 |
About CTIC
The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers. The company’s Cigna Healthcare segment offers medical, pharmacy, behavioral health, dental, and other product... [Read more]
Financial Performance
In 2024, The Cigna Group's revenue was $247.12 billion, an increase of 26.56% compared to the previous year's $195.27 billion. Earnings were $3.43 billion, a decrease of -33.50%.
Financial StatementsAnalyst Summary
According to 17 analysts, the average rating for CI stock is "Strong Buy." The 12-month stock price target is $382.71, which is an increase of 38.14% from the latest price.
News
Cigna: Looks More Interesting Here Than UnitedHealth Group
Cigna offers a lower-risk profile after selling its Medicare business, avoiding Medicare headwinds impacting peers like UnitedHealth Group. However, the stock price has fallen alongside UNH. Recent ea...
5 Dividend Stocks With Solid Returns And More Growth Ahead
Sector by sector, U.S. dividend stocks have outperformed so far this year, with historically dividend-friendly industries surpassing those with a more growth-oriented focus.
Cigna's 2nd quarter profits beat Wall Street's expectations
Cigna beat Wall Street estimates for second-quarter profit on Thursday, helped by strength in its pharmacy benefit management business.
Cigna Sees Elevated Cost Trends To Continue Into Next Year
Smart beta and active strategies helped four diverse ETFs outperform and hit 52-week highs amid shifting macro trends. From defensive utilities to innovation-driven tech, these ETFs are thriving by re...
The Cigna Group (CI) Q2 2025 Earnings Call Transcript
The Cigna Group (NYSE:CI) Q2 2025 Earnings Conference Call July 31, 2025 8:30 AM ET Company Participants Ann M. Dennison - Executive VP & CFO Brian C.
Cigna Profits Hit $1.5 Billion Despite Higher Costs
The Cigna Group reported a second quarter profit of $1.5 billion as its Evernorth health service business performs well and despite rising costs in its employer health benefits business.
Cigna beats profit estimate on robust health services growth
Cigna beat Wall Street estimate for second-quarter profit on Thursday, helped by strength in its pharmacy benefit management business.
The Cigna Group Reports Strong Second Quarter 2025 Results, Reaffirms 2025 Adjusted EPS Outlook
Total revenues for the second quarter 2025 increased 11% to $67.2 billion Shareholders' net income for the second quarter 2025 was $1.5 billion, or $5.71 per share Adjusted income from operations1 for...
Evercore ISI's Umer Raffat on finding value in the beaten-down health care sector
Umer Raffat, Evercore ISI senior analyst, joins 'The Exchange' to discuss if there's a turnaround coming for the health care sector.
The Cigna Group Declares Quarterly Dividend
BLOOMFIELD, Conn. , July 22, 2025 /PRNewswire/ -- The Board of Directors of The Cigna Group (NYSE: CI) today declared a cash dividend of $1.51 per share of its common stock, payable on September 18, 2...
10 Undervalued Dividend Growth Stocks: July 2025
I rank a selection of undervalued dividend growth stocks in Dividend Radar and present the top ten stocks for consideration. I use two valuation screens, one based on my fair value estimate and anothe...
Most Managed Care Insurers Expected To See Q2 2025 Drops In Revenue, Net Income
A majority of publicly traded US health insurers are expected to post QoQ declines in revenue and net income in Q2, according to an S&P Global Market Intelligence analysis of sell-side analyst forecas...
Cigna Group: Is The Value Real Or Are Investors Just Stuck In Neutral?
The Cigna Group's risk/reward is balanced after a rebound; I rate it Hold—worth keeping if owned, but not a compelling buy right now. The Evernorth pharmacy benefits arm drives growth, but regulatory ...
Cigna: Price Pullback Is A Great Opportunity
Cigna trades at a significant discount to the S&P 500, offering a higher yield and faster dividend growth, making it attractive for total return investors. CI's robust earnings growth is fueled by its...
Don't Miss Out On These 3 Dirt-Cheap SWANs
We prefer to buy and hold stocks with a significant margin of safety. Today, we're highlighting a global tech and e-commerce juggernaut, the leading life sciences REIT, and a major managed healthcare ...
The Cigna Group Foundation Addresses Mental Health and Housing Stability for Veterans with $3 Million in Grants
Nonprofits are encouraged to apply now for 2025 funding The Cigna Group Foundation committed $9 million in 2024 to address veteran mental health, distributing $3 million each year through 2026 In firs...
The Cigna Group Foundation Announces Grants to 24 Nonprofits, Builds on Momentum to Help Address Youth Mental Health Crisis
BLOOMFIELD, Conn. , June 30, 2025 /PRNewswire/ -- The Cigna Group Foundation, the philanthropic arm of The Cigna Group (NYSE: CI), today announced its second round of grant recipients supporting youth...
Cigna Enables Coverage for RhinAer®
MOUNTAIN VIEW, Calif.--(BUSINESS WIRE)--Aerin Medical Inc., a leader in minimally invasive solutions for chronic nasal conditions, today announced that Cigna Healthcare will provide coverage for RhinA...
The Cigna Group's Second Quarter 2025 Earnings Release Details
BLOOMFIELD, Conn. , June 25, 2025 /PRNewswire/ -- Global health company The Cigna Group (NYSE: CI) will release its second quarter 2025 financial results on Thursday, July 31, 2025, and will host a co...
Cigna sues Bristol Myers over alleged monopoly for multiple myeloma drug Pomalyst
Cigna sued Bristol Myers on Tuesday, accusing the drugmaker of violating federal antitrust law by maintaining a monopoly over a blockbuster multiple myeloma drug sold under the brand name Pomalyst.
US health chief Kennedy met with insurers on prior authorization requirements
U.S. health secretary Robert F. Kennedy Jr. met with major health insurers on Monday, extracting pledges that they will take additional measures to simplify their requirements for prior approval on me...
Cigna: Valuation Discount To Historical And Sector Averages Persists
Cigna has transformed into a diversified healthcare platform, focusing on high-margin corporate insurance and pharmacy services while divesting non-core assets. Despite margin pressures, Cigna's servi...
Wake Up Wall Street - 2 Massively Mispriced Dividend Gems
I believe the odds favor long-term market gains. Analysts' optimism supports my view that overlooked areas offer the best opportunities now. That's why I'm focusing on two dividend stocks with rising ...
Cigna Healthcare Unveils Industry-Leading AI-Powered Digital Tools for a Simple and Reliable Customer Experience
New features blend innovation, responsible AI, and human interactions to better support customers in their health care journeys As new data show 4 out of 5 U.S. adults don't feel confident in their kn...